Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04596150 |
|
Recruitment Status :
Active, not recruiting
First Posted : October 22, 2020
Last Update Posted : February 23, 2023
|
Sponsor:
CytomX Therapeutics
Information provided by (Responsible Party):
CytomX Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2023 |
| Estimated Study Completion Date : | April 30, 2023 |